T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Honeywell
HON
$72.9B
| $229M | 0.05% |
2,189,105
-209,852
| -9% | -$21.6M |
|
377
First American
FAF
$7.32B
| $225M | 0.05% |
5,605,299
-449,007
| -7% | -$16.7M |
|
378
PVH
PVH
$3.91B
| $225M | 0.05% |
2,391,010
-161,285
| -6% | -$15.2M |
|
379
Baxter International
BAX
$14.3B
| $224M | 0.05% |
4,953,318
-12,551
| -0.3% | -$551K |
|
380
ManpowerGroup
MAN
$2.62B
| $224M | 0.05% |
3,478,355
-385,419
| -10% | -$29.9M |
|
381
Graco
GGG
$13.5B
| $224M | 0.05% |
8,493,210
-2,965,110
| -26% | -$79.7M |
|
382
Matador Resources
MTDR
$6.51B
| $222M | 0.05% |
11,223,351
-216,286
| -2% | -$4.66M |
|
|
JBTM
383
JBT Marel
JBTM
$6.32B
| $222M | 0.05% |
3,623,821
-300,480
| -8% | -$17.5M |
|
384
Alnylam Pharmaceuticals
ALNY
$29.6B
| $222M | 0.05% |
3,996,142
+2,712,060
| +211% | +$171M |
|
385
Jefferies Financial Group
JEF
$12.7B
| $221M | 0.05% |
14,261,851
+7,499,704
| +111% | +$115M |
|
|
IMS
386
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $220M | 0.05% |
8,687,315
+135,195
| +2% | +$3.47M |
|
387
Synchrony
SYF
$25.5B
| $220M | 0.05% |
8,682,958
+7,023,167
| +423% | +$204M |
|
388
EastGroup Properties
EGP
$10.8B
| $219M | 0.05% |
3,171,388
-38,541
| -1% | -$2.44M |
|
389
Mettler-Toledo International
MTD
$28.8B
| $219M | 0.05% |
598,784
-14,599
| -2% | -$5.33M |
|
390
McCormick & Company Non-Voting
MKC
$14.2B
| $217M | 0.05% |
4,061,814
-1,354,336
| -25% | -$66.1M |
|
391
Sabre
SABR
$803M
| $216M | 0.05% |
8,079,927
+565,459
| +8% | +$15.9M |
|
392
Post Holdings
POST
$3.56B
| $212M | 0.05% |
3,922,150
+148,219
| +4% | +$7.17M |
|
393
Descartes Systems
DSGX
$6.78B
| $210M | 0.04% |
11,027,786
+36,100
| +0.3% | +$703K |
|
394
Automatic Data Processing
ADP
$108B
| $210M | 0.04% |
2,287,334
-669,795
| -23% | -$59.1M |
|
|
PXD
395
DELISTED
Pioneer Natural Resource Co.
PXD
| $208M | 0.04% |
1,377,734
-563,050
| -29% | -$88.3M |
|
396
Liberty Latin America Class C
LILAK
$1.66B
| $208M | 0.04% |
7,489,139
+5,113,966
| +215% | +$170M |
|
397
Popular Inc
BPOP
$11.2B
| $207M | 0.04% |
7,076,909
-2,701
| -0% | -$79.5K |
|
398
KeyCorp
KEY
$24.3B
| $207M | 0.04% |
18,747,912
+17,186,065
| +1,100% | +$205M |
|
|
SPLK
399
DELISTED
Splunk Inc
SPLK
| $207M | 0.04% |
3,819,811
+2,946,917
| +338% | +$156M |
|
400
EOG Resources
EOG
$75.2B
| $206M | 0.04% |
2,467,249
-326,050
| -12% | -$26.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.